UBS AM’s Fulcrum Therapeutics FULC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-703
| Closed | -$2.03K | – | 2655 |
|
|
2025
Q1 | $2.03K | Buy |
+703
| New | +$2.03K | ﹤0.01% | 2633 |
|
|
2023
Q3 | – | Sell |
-25,699
| Closed | -$73.2K | – | 2625 |
|
|
2023
Q2 | $73.2K | Hold |
25,699
| – | – | ﹤0.01% | 2655 |
|
|
2023
Q1 | $73.2K | Buy |
25,699
+10,899
| +74% | +$31.1K | ﹤0.01% | 2655 |
|
|
2022
Q4 | $108K | Hold |
14,800
| – | – | ﹤0.01% | 2490 |
|
|
2022
Q3 | $120K | Hold |
14,800
| – | – | ﹤0.01% | 2667 |
|
|
2022
Q2 | $72.5K | Hold |
14,800
| – | – | ﹤0.01% | 2662 |
|
|
2022
Q1 | $350K | Buy |
+14,800
| New | +$350K | ﹤0.01% | 2558 |
|